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Abstract: Metabolic engineering has enabled the production of a wealth of chemicals with
microorganisms. Classic strategies for pathway engineering rely on the expression of heterologous
enzymes in a host that convert native intermediates into target products. Although traditional
implementations are based on open-loop control, recent advances in gene circuit engineering
offer opportunities for building feedback systems that dynamically control pathway activity.
Here we present a framework for the design of metabolic control circuits based on multiobjective
optimization. We show that positive and negative feedback loops produce a range of optimal
dynamics along a Pareto front. Such regulatory loops define connectivities between pathway
intermediates and enzymatic genes that trade-off metabolic production against the burden to the
host. Our results lay the groundwork for the automated design of gene circuitry in applications
at the interface of synthetic biology and metabolic engineering.
Keywords: Metabolic engineering; Synthetic Biology; multiobjective optimization
1. INTRODUCTION
Metabolic engineering has been extremely successful in the
production of valuable chemicals with genetically modified
microorganisms (Lee et al., 2019). Microbial strains can
be equipped with enzymatic genes that catalyze native
metabolites into target chemical products. A common
strategy in metabolic engineering is the “push-pull-block”
approach (Liu et al., 2018). This involves up-regulation of
native enzymes to push flux from precursors, expression
of heterologous enzymes to pull flux towards the desired
product, and knockdown of native pathways to block the
diversion of flux away from production.
In traditional pathway engineering, foreign enzymes are
expressed at constant levels from inducible or constitutive
promoters. This corresponds to an open-loop strategy
where pathway expression cannot adapt to perturbations
or changes in bioreactor conditions (Venayak et al., 2015).
Moreover, the diversion of metabolic flux from native
processes towards chemical production alters the energetic
budget of the host. This causes metabolic imbalances
that often impair growth and limit production. Such
imbalances arise from e.g. the accumulation of toxic
intermediates or the depletion of key metabolites for
survival. Pathway expression also draws resources from
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the genetic machinery of the host, thus affecting the
biosynthesis of native proteins needed for growth. As
a result, a central challenge in metabolic engineering
is to determine enzyme expression levels that maximise
production with a reduced footprint on the host.
Last decade has witnessed the birth of dynamic metabolic
engineering, a new technology that aims to use gene
regulatory circuits in conjunction with engineered path-
ways (Zhang et al., 2012; Xu et al., 2014; Doong et al.,
2018). The core principle is to design feedback control
circuits that adapt pathway expression in response to the
metabolic state of the host (Mannan et al., 2017; Stevens
and Carothers, 2015). These control circuits can poten-
tially resolve many of the challenges typically encountered
in pathway engineering (Oyarzu´n and Stan, 2013). Yet to
date there are no systematic strategies to navigate the
design space and single out candidate circuits that can
achieve given performance specifications.
Here we present a circuit design strategy based on multi-
objective optimization. Our approach automatically finds
circuit architectures and parameters that optimally trade-
off the production flux against the metabolic burden on
the host. This is a first step towards automated design
of control circuits for engineered pathways and can speed
up the iterations between circuit design, implementation
and testing. As a proof-of-principle, we illustrate our ap-
proach with a toy pathway that contains some of the
key elements encountered in real applications. We show
that optimal solutions produce Pareto-optimal fronts with
different feedback loops between pathway intermediates
and metabolic genes.
2. DYNAMIC MODEL OF AN ENGINEERED
PATHWAY
We consider a heterologous pathway that branches from a
native pathway that is essential for growth (see Fig. 1). We
denote by x0 and x1 the concentration of the metabolites
of the host and synthetic pathway, respectively. The pool
of native metabolite (x0) is synthesized at a rate Vin and
consumed by a native enzyme e0. The synthetic pathway
contains two enzymes, denoted by e1 and e2.
We model pathway kinetics with mass balance equations:
x˙0 = Vin − V0 − V1 − λx0,
x˙1 = V1 − V2 − λx1, (1)
where Vi are the fluxes of each reaction in Fig. 1B and λ is
the growth rate of the culture. In particular, the reaction
flux V2 represents the flux through the engineered pathway.
We model the expression of the pathway enzymes by:
e˙1 = u1 − λe1,
e˙2 = u2 − λe2, (2)
with ui being the expression rate of the pathway genes.
The reaction rates are assumed to follow irreversible
Michaelis-Menten kinetics of the form:
V0 = e0 · kcat 0 · x0
KM0 + x0
, (3)
V1 = e1 · kcat 1 · x0
KM1 + x0
, (4)
V2 = e2 · kcat 2 · x1
KM2 + x1
, (5)
with kinetic parameters (kcat i,KM i) that are specific to
each enzyme.
In dynamic pathway engineering, gene regulatory circuits
are employed to adapt enzyme expression levels in re-
sponse to a metabolic signal in the host. A common strat-
egy is to use pathway intermediates to modulate the ex-
pression of enzymatic genes through metabolite-responsive
transcription factors. The dose-response curve of such
transcription factors can be modelled by a sigmoidal dose-
response curve (Mannan et al., 2017) of the form
σ+i (x) = ai
xn
θni + x
n
(gene activation),
σ−i (x) = ai
θni
θni + x
n
(gene repression),
where the parameter ai represents the maximal expression,
θi is a regulatory threshold, and n is an effective Hill
coefficient.
For the system in Fig. 1B, we seek to find gene control
circuits that maximize the production flux V2 with a
low footprint on enzyme expression. To formulate these
specifications as a multiobjective optimization problem,
we parameterize the enzyme expression rates ui by the
general function:
ui(x1) = bi + |ηi| ·
(
1 + ηi
2
· σ+i (x1) +
1− ηi
2
· σ−i (x1)
)
,
(6)
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Fig. 1. Design of gene circuits for metabolic engineering.
(A) Engineered pathways are built by expressing for-
eign enzymes into a target host. (B) Exemplar path-
way described in Eqs. (1)–(2). We seek gene circuits
that optimally trade-off the production flux V2 against
the burden caused by expression of enzymes e1 and
e2.
where ηi ∈ {−1, 0, 1} is an integer variable and bi de-
scribes the basal expression rate for each enzyme. The
parameterization in (6) encodes all the regulatory circuits
shown in Fig. 1B into a single function that is amenable
for simultaneous optimization of regulatory parameters,
comprised in the Hill functions σ+i and σ
−
i , and regulatory
architectures, described by the integers in ηi. This formu-
lation accounts for two regulated genes and three modes
of regulation (activation, repression, and no regulation)
exerted by the metabolite x1. Each regulatory circuit can
thus be described by a two dimensional integer vector
η = [η1, η2] and a six dimensional, real positive vector of
regulatory parameters w = [a1, a2, θ1, θ2, b1, b2].
3. CIRCUIT DESIGN AS AN OPTIMIZATION
PROBLEM
Our goal is to design a gene circuit that maximizes the
production of the metabolite of interest while keeping
the burden of enzyme production at a minimum. To this
aim we define two integral objective functions for our
optimization problem. The first objective accounts for the
flux through the production pathway:
J1 =
∫ T
0
|V2(t)− Vin|dt. (7)
The second objective describes the genetic burden caused
by pathway expression:
J2 =
∑
i
∫ T
0
ui dt. (8)
In both objectives, T is a pre-specified final time. The
objective function J1 decreases when the production flux
V2 is high and close to the feed flux Vin. But since this
requires high enzyme expression, a low J1 can be only
achieved at the expense of a large value for objective J2.
To find the optimal circuit architectures that trade-off
production against enzyme expression, we formulate the
following optimization problem:
min
η,w
[J1(η, w), J2(η, w)]
subject to:
i) The dynamics of the pathway in eq. (1)–(2) and a
given initial condition.
ii) Upper and lower bounds for the decision variables:
wL ≤ w ≤ wU
−1 ≤ η ≤ 1
iii) Inequality constraints to avoid the potential toxic
effects caused by high concentratin of product x1:
x1(t) ≤ x1max, for all t. (9)
To solve the resulting mixed-integer multiobjective op-
timization problem, we employ an ε-constraint strategy
combined with mixed-integer hybrid global optimization
algorithms. We employ the global heuristic eSS proposed
in Egea et al. (2010) combined with MISQP by Exler and
Schittkowski (2007) as a local solver. This optimization
strategy has been shown to perform well for mixed-integer
problems involving gene circuit design and allow for an
efficient search over the space of circuit architectures and
parameters (Otero-Muras and Banga, 2017).
4. EXAMPLE APPLICATION
As a proof of concept we solved the multiobjective problem
for a representative set of kinetic parameters kcat i = 12s
−1
and KM i = 10µM for all enzymes (i = 0, 1, 2), with
a growth rate λ = 3 · 10−4s−1, influx Vin = 1µMs−1,
and concentration of the native enzyme e0 = 0.05µM.
We considered the parameter bounds given in Table 1
and included an additional upper bound for the product
concentration x1max = 180µM.
Table 1. Parameter bounds for the optimiza-
tion problem.
a1 a2 θ1 θ2 b1 b2
wL 10−7 10−7 10−2 10−2 10−5 10−5
wU 10−4 9 · 10−4 10 10 10−4 10−4
units µMs−1 µM µMs−1
We implemented the ε-constraint strategy by setting ob-
jective J2 as a constraint in a single objective problem
to minimize J1. To this end we consider seven intervals
corresponding to J2 ≤ 1, 1 < J2 ≤ 2, 2 < J2 ≤ 3,
3 < J2 ≤ 4, 5 < J2 ≤ 6 and J2 > 6. The resulting Pareto
front of solutions is shown in Fig. 2, together with the titer
of product x1 for each optimal circuit, defined as:
titer =
∫ T
0
V2(t) dt. (10)
The extremes points of the Pareto front, labelled as P1
and P7 in Fig. 2, correspond to solutions that account
for the single objectives J2 and J1, respectively. The
average computational time needed by the solver for each
constrained single objective problem is ∼ 650s and no
solution exceeded 1500s using Matlab 2017b on a PC with
Intel 2.8 GHz Xeon processor.
The resulting Pareto front contains three different circuit
architectures (Fig. 2): solution P1 corresponds to the open
loop case (η1 = η2 =0). Solutions P2 to P5 require
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Fig. 2. Pareto front and optimal regulatory architectures.
The inset shows the titer for each solution in µM,
computed according to Eq. (10). Low values of J1
correspond to better production performance. Opti-
mal parameters are shown in Table 2.
activation of the consumption enzyme e2 (η1 = 0 and
η2 = 1), which corresponds to a negative feedback loop
of x1 onto itself. Solutions P6 and P7 require repression
of the consumption enzyme e2 (η1 = 0 and η2 = −1),
and thus correspond to a positive feedback loop of x1 onto
itself. In all cases, optimal solutions do not need control on
the expression of the first pathway enzyme (e1). In Figs.
3-4 we show the optimal trajectories of metabolic product
(x1), pathway enzymes (e1 and e2) and metabolic fluxes
for all optimal solutions.
Table 2. Optimal parameter values for each
solution along the Pareto front in Fig. 2. The
Hill coefficient was fixed to n = 2. Units are
given in Table 1.
a1 a2 θ1 θ2 b1 b2
P1 9.5 · 10−5 3.2 · 10−4 6.3 · 10−1 1.9 1.9 · 10−5 1.7 · 10−5
P2 6.9 · 10−7 5.2 · 10−5 8.4 9.9 5 · 10−5 1 · 10−5
P3 1.9 · 10−5 9.2 · 10−5 9.9 9.9 8.8 · 10−5 1.9 · 10−5
P4 9.8 · 10−5 5.3 · 10−4 3.0 9.9 10−4 6.6 · 10−5
P5 2.8 · 10−5 8.9 · 10−4 6.9 5.7 9.9 · 10−5 9.1 · 10−5
P6 6.1 · 10−5 2.6 · 10−4 7.3 9.9 9.4 · 10−5 1 · 10−5
P7 8.3 · 10−6 2.7 · 10−4 5.1 10 9.9 · 10−5 1 · 10−4
Our results suggest that both positive and negative feed-
back can lead to an optimal trade-off between production
and burden to the host. Solutions from P3 to P7 perform
significantly better in terms of titer than solutions P1 and
P2. Note that solution P1 accounts for one objective only,
resulting in a slow, 1st-order like response. In contrast,
solutions that account for the second objective (from P2
to P5) display increasingly faster and nonlinear responses
as we move along the Pareto front.
5. DISCUSSION
Here we have addressed the regulation of heterologous
pathways using a multiobjetive dynamic optimization ap-
proach. We show that encoding the design problem in
a mixed-integer framework enables an efficient search
through the topology and parameter spaces simultane-
ously. Our multiobjective perspective allows us to find
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Fig. 4. Optimal metabolic fluxes in the heterologous and
native pathway for each solution along the Pareto
front.
solutions that optimally trade-off performance in terms
of production and burden to the host, as quantified by
the cost of protein production. The resulting Pareto front
suggests that open loop control imposes the lowest burden
at the expense of poor production. A positive feedback
architecture lies at the other extreme of the Pareto front,
showing high production but at the cost of high protein
production. A negative feedback architecture lies in be-
tween these two extremes, with a good performance and
intermediate values of burden. Our results show promise
for future applications of multiobjective optimization in
the design of complex circuitry that combine gene expres-
sion with metabolic activity.
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